During your trial you will have complete digital access to FT.com with everything in both of our Standard Digital and Premium Digital packages.
Standard Digital includes access to a wealth of global news, analysis and expert opinion. Premium Digital includes access to our premier business column, Lex, as well as 15 curated newsletters covering key business themes with original, in-depth reporting. For a full comparison of Standard and Premium Digital,Change the plan you will roll onto at any time during your trial by visiting the “Settings & Account” section.
You may also opt to downgrade to Standard Digital, a robust journalistic offering that fulfils many user’s needs. Compare Standard and Premium DigitalAny changes made can be done at any time and will become effective at the end of the trial period, allowing you to retain full access for 4 weeks, even if you downgrade or cancel.
Ban big pharma.
At $1,349 a month - for life - it would be cheaper and more socially useful to give every patient a personal trainer.
Truly amazing business strategy: BigPharma makes you obese (by destroying your immune system), and then promises to come up with another drug that fixes obesity. Of course diet and exercise are not part of the fix ... 🤣
Create the problem, sell the solution. Anything that reduces obesity should be fk'g free as a matter of public policy. As a matter of national interest...Put that shyt in the air.
Create the problem, sale the solution. Anything that reduces obesity should be fk'g free as a matter of public policy. As a matter of national interest...Put that shyt in the air.
GeorgeMcnee forget the running, I can just take this! 😆
Start exercising...? 👀
One might say, we're hungry for obesity drugs.